Insulins Glargine and gluLisine strAtegy Versus Premixed Insulin strAteGy: a cOmparative Study

NCT01121835 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

934

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: INSULIN GLARGINE
DRUG: INSULIN GLULISINE
DRUG: PREMIXED INSULIN

Sponsor

Sanofi